July 7, 2020 / 10:47 AM / a month ago

BRIEF-Chromadex And NIH-NIAID Rocky Mountain Laboratories Announce Study To Assess Therapeutic Potential Of Niagen® In Covid-19 Animal Models

July 7 (Reuters) - Chromadex Corp:

* CHROMADEX AND THE NIH-NIAID ROCKY MOUNTAIN LABORATORIES ANNOUNCE STUDY TO ASSESS THE THERAPEUTIC POTENTIAL OF NIAGEN® IN COVID-19 ANIMAL MODELS

* CHROMADEX CORP - STUDY ON CHROMADEX’S NR INGREDIENT TO BE CONDUCTED AT NIH-NIAID’S ROCKY MOUNTAIN LABS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below